215 related articles for article (PubMed ID: 32487998)
21. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
22. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
23. [LncRNA RUNX1-IT1 regulating malignant pleomorphic adenoma via mir-195/CyclinD1].
Wei JS; Sun X; Xu JB; Chen YD
Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):85-90. PubMed ID: 36973850
[TBL] [Abstract][Full Text] [Related]
24. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA CPS1-IT1 Suppresses Cell Proliferation and Metastasis in Human Lung Cancer.
Xiaoguang Z; Meirong L; Jingjing Z; Ruishen Z; Qing Z; Xiaofeng T
Oncol Res; 2017 Mar; 25(3):373-380. PubMed ID: 27662619
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
28. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
29. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
30. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
31. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways.
Yan PH; Wang L; Chen H; Yu FQ; Guo L; Liu Y; Zhang WJ; Bai YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8287-8294. PubMed ID: 31646558
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MIR155HG facilitates pancreatic cancer progression through negative regulation of miR-802.
Qin Y; Liu X; Pan L; Zhou R; Zhang X
J Cell Biochem; 2019 Oct; 120(10):17926-17934. PubMed ID: 31161625
[TBL] [Abstract][Full Text] [Related]
33. LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves' disease.
Huang FJ; Liu YL; Wang J; Zhou YY; Zhao SY; Qin GJ
Cell Cycle; 2022 May; 21(9):921-933. PubMed ID: 35220890
[TBL] [Abstract][Full Text] [Related]
34. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
Yang J; Li C; Li H; E C
J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
Guo W; Zhong K; Wei H; Nie C; Yuan Z
PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
38. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
